Real-World Data Confirm Efficacy of Dupilumab in Severe EoE

Dupilumab demonstrated real-world efficacy in patients with severe, treatment-refractory fibrostenotic eosinophilic esophagitis, most of whom would not have qualified for prior clinical trials.
Medscape Medical News

source https://www.medscape.com/viewarticle/996536?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?